It also leads to changes in endocrine hormones (low levels of progesterone and high levels of luteinizing hormone, testosterone, estrogen, and prolactin) and metabolic disorders  such as dyslipidemia, obesity, inflammation, and high blood pressure (Abasian et al., 2018). This evidence concerns the gene PRL and Other metabolic disease.